218 related articles for article (PubMed ID: 32601104)
1. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.
Wang J; Yu L; Jiang H; Zheng X; Zeng S
Drug Metab Dispos; 2020 Sep; 48(9):759-768. PubMed ID: 32601104
[TBL] [Abstract][Full Text] [Related]
2. Role of Drug-metabolizing Enzymes in Cancer and Cancer Therapy.
Feng S; Li A; Zheng YC; Liu HM
Curr Drug Metab; 2020; 21(1):67-76. PubMed ID: 31902352
[TBL] [Abstract][Full Text] [Related]
3. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
[TBL] [Abstract][Full Text] [Related]
4. Methylation Modification, Alternative Splicing, and Noncoding RNA Play a Role in Cancer Metastasis through Epigenetic Regulation.
Yu B; Yu X; Xiong J; Ma M
Biomed Res Int; 2021; 2021():4061525. PubMed ID: 34660788
[TBL] [Abstract][Full Text] [Related]
5. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
[TBL] [Abstract][Full Text] [Related]
6. Infection-associated epigenetic alterations in gastric cancer: New insight in cancer therapy.
Fattahi S; Kosari-Monfared M; Ghadami E; Golpour M; Khodadadi P; Ghasemiyan M; Akhavan-Niaki H
J Cell Physiol; 2018 Dec; 233(12):9261-9270. PubMed ID: 30076708
[TBL] [Abstract][Full Text] [Related]
7. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
[TBL] [Abstract][Full Text] [Related]
8. Interplay between regulation by methylation and noncoding RNAs in cancers.
Lu CX; Wu XL; Zhang GY; Gu XT; Ma X; He DX
Eur J Cancer Prev; 2018 Jul; 27(4):418-424. PubMed ID: 29557800
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
Li Y; Li Z; Zhu WG
Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic perspectives on cancer chemotherapy response.
Liu MZ; McLeod HL; He FZ; Chen XP; Zhou HH; Shu Y; Zhang W
Pharmacogenomics; 2014 Apr; 15(5):699-715. PubMed ID: 24798726
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
Akram F; Tanveer R; Andleeb S; Shah FI; Ahmad T; Shehzadi S; Akhtar AM; Syed G
Technol Cancer Res Treat; 2024; 23():15330338241250317. PubMed ID: 38780251
[TBL] [Abstract][Full Text] [Related]
14. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
Zeng Z; Zheng W; Hou P
Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
[TBL] [Abstract][Full Text] [Related]
15. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.
Maruyama R; Suzuki H; Yamamoto E; Imai K; Shinomura Y
Tumour Biol; 2012 Apr; 33(2):277-85. PubMed ID: 22219034
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
17. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
Hattinger CM; Serra M
Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets for epigenetic therapy of cancer.
Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
Curr Pharm Biotechnol; 2009 Feb; 10(2):161-5. PubMed ID: 19199948
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]